H.R. 6703: Lower Health Care Premiums for All Americans Act
The "Lower Health Care Premiums for All Americans Act" is designed to make health insurance more affordable and accessible. It achieves this through several key provisions:
Group Health Plans for Employers
The bill permits associations of employers to establish and maintain group health plans. This move is intended to help smaller employers join forces to provide health insurance options, allowing them to negotiate better premiums and coverage terms.
Premium Rules and Protections
It establishes specific rules governing health insurance premiums, ensuring that they are fair and just. Additionally, the bill includes protections against discrimination based on health issues, such as pre-existing conditions, which means insurers cannot deny coverage or charge higher premiums based on an individual's health status.
Pharmacy Benefit Managers Reporting
The legislation requires pharmacy benefit managers (PBMs) to report more detailed information to group health plans regarding drug spending. This includes costs linked to various dispensing channels, and it aims to promote transparency in prescription drug costs. There are also provisions to ensure compliance with privacy regulations to protect patient information.
Oversight of Pharmacy Benefits
There will be increased oversight of pharmacy benefit management services. Starting 30 months after the bill is enacted, entities involved in managing pharmacy benefits must provide extensive reporting to health plans. This includes disclosing information on drug spending, reimbursements, and pricing, fostering a more accountable and transparent system.
Penalties for Non-Compliance
The bill introduces penalties for pharmacy benefit managers who do not comply with the reporting requirements. This aims to encourage adherence to the new regulations and ensure that relevant information is made available to health plan participants and beneficiaries.
Access to Information
Importantly, the act ensures that beneficiaries have access to vital information regarding drug spending, which is intended to empower patients in their health care decisions and promote informed choices.
Relevant Companies
- PFE (Pfizer Inc.) - As a significant player in pharmaceuticals, Pfizer may be impacted by increased transparency in drug pricing and potential changes in regulations affecting how drugs are priced and reimbursed by health plans.
- MSFT (Microsoft Corporation) - If they are involved in providing technology solutions for health plans or pharmacy benefit managers, changes in reporting and compliance requirements could necessitate adjustments to their offerings.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
1 sponsor
Actions
15 actions
| Date | Action |
|---|---|
| Dec. 17, 2025 | Considered as unfinished business. |
| Dec. 17, 2025 | Considered under the provisions of rule H. Res. 953. |
| Dec. 17, 2025 | DEBATE - The House proceeded with one hour of debate on H.R. 6703. |
| Dec. 17, 2025 | Motion to reconsider laid on the table Agreed to without objection. |
| Dec. 17, 2025 | Ms. Underwood moved to recommit to the Committee on Energy and Commerce. |
| Dec. 17, 2025 | On motion to recommit Failed by the Yeas and Nays: 210 - 218 (Roll no. 348). |
| Dec. 17, 2025 | On passage Passed by the Yeas and Nays: 216 - 211 (Roll no. 349). |
| Dec. 17, 2025 | Passed/agreed to in House: On passage Passed by the Yeas and Nays: 216 - 211 (Roll no. 349). |
| Dec. 17, 2025 | POSTPONED PROCEEDINGS - At the conclusion of debate on H.R. 6703, the Chair put the question on motion to recommit and by voice vote, announced the noes had prevailed. Ms. Underwood demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced. |
| Dec. 17, 2025 | Rule provides for consideration of H.R. 6703, H.R. 498 and H.R. 3492. The resolution provides for consideration of H.R. 6703 and H.R. 498 under a closed rule and H.R. 3492 under a structured rule with one hour of general debate and one motion to recommit on each bill. |
| Dec. 17, 2025 | Rules Committee Resolution H. Res. 953 Reported to House. Rule provides for consideration of H.R. 6703, H.R. 498 and H.R. 3492. The resolution provides for consideration of H.R. 6703 and H.R. 498 under a closed rule and H.R. 3492 under a structured rule with one hour of general debate and one motion to recommit on each bill. |
| Dec. 17, 2025 | The previous question on the motion to recommit was ordered pursuant to clause 2(b) of rule XIX. |
| Dec. 17, 2025 | The previous question was ordered pursuant to the rule. |
| Dec. 15, 2025 | Introduced in House |
| Dec. 15, 2025 | Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
